Literature DB >> 7332929

Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

J R Nevins.   

Abstract

Results obtained with certain adenovirus host range mutants (dl312 and hr1) have demonstrated that a functional viral E1A gene is required for the accumulation of early viral mRNA. In this report, it is demonstrated that the failure to accumulate early viral mRNA in E1A mutant-infected cells is due to a lack of transcription of the appropriate transcription units. The E1A gene product appears to enhance transcription of the early transcription units since there is not an absolute requirement for its function. At low multiplicities of infection, transcription from the early transcription units can be detected but at a later time. By increasing the multiplicity of infection, this show activation of early transcription can be enhanced, even though at this multiplicity all input viruses are still mutant. It was also found that early transcription could be detected in mutant-infected cells if the virus was added to cells in which protein synthesis was inhibited prior to infection. Thus inhibition of cellular protein synthesis can mimic the function of the E1A gene. It is proposed that the role of the E1A gene product in the activation of early viral transcription is to inactivate a cellular factor that prevents transcription from the early viral promoters.

Mesh:

Substances:

Year:  1981        PMID: 7332929     DOI: 10.1016/0092-8674(81)90304-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  267 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Adenovirus infection of differentiated F9 cells results in a global shut-off of differentiation-induced gene expression.

Authors:  R J Weigel; J R Nevins
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.

Authors:  V B Kraus; E Moran; J R Nevins
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.

Authors:  X C Li; W L Huang; S J Flint
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

5.  Characterization of the 55-residue protein encoded by the 9S E1A mRNA of species C adenovirus.

Authors:  Matthew S Miller; Peter Pelka; Gregory J Fonseca; Michael J Cohen; Jenna N Kelly; Stephen D Barr; Roger J A Grand; Andrew S Turnell; Peter Whyte; Joe S Mymryk
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector.

Authors:  R Ramalingam; S Rafii; S Worgall; N R Hackett; R G Crystal
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

9.  A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Authors:  Elizabeth S Gabitzsch; Younong Xu; Lois H Yoshida; Joseph Balint; Richard B Gayle; Andrea Amalfitano; Frank R Jones
Journal:  Immunol Lett       Date:  2008-12-13       Impact factor: 3.685

10.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.